Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review.

Bax C, Taverna G, Eusebio L, Sironi S, Grizzi F, Guazzoni G, Capelli L.

Cancers (Basel). 2018 Apr 18;10(4). pii: E123. doi: 10.3390/cancers10040123. Review.

2.

Prostate Cancer: From Genomics to the Whole Body and Beyond.

Grizzi F, Taverna G, Cote RJ, Guazzoni G.

Biomed Res Int. 2017;2017:8707690. doi: 10.1155/2017/8707690. Epub 2017 Nov 9. No abstract available.

3.

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review.

Capelli L, Taverna G, Bellini A, Eusebio L, Buffi N, Lazzeri M, Guazzoni G, Bozzini G, Seveso M, Mandressi A, Tidu L, Grizzi F, Sardella P, Latorre G, Hurle R, Lughezzani G, Casale P, Meregali S, Sironi S.

Sensors (Basel). 2016 Oct 14;16(10). pii: E1708. Review.

4.

Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

Caturegli P, Di Dalmazi G, Lombardi M, Grosso F, Larman HB, Larman T, Taverna G, Cosottini M, Lupi I.

Am J Pathol. 2016 Dec;186(12):3225-3235. doi: 10.1016/j.ajpath.2016.08.020. Epub 2016 Oct 15.

5.

An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men.

Bozzini G, Provenzano M, Buffi N, Seveso M, Lughezzani G, Guazzoni G, Mandressi A, Taverna G.

BMC Urol. 2016 Jun 8;16(1):25. doi: 10.1186/s12894-016-0144-8.

6.

Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Lazzeri M, Hurle R, Casale P, Buffi N, Lughezzani G, Fiorini G, Peschechera R, Pasini L, Zandegiacomo S, Benetti A, Taverna G, Guazzoni G, Barbagli G.

Ther Adv Urol. 2016 Apr;8(2):91-9. doi: 10.1177/1756287215621234. Epub 2015 Dec 16. Review.

7.

Sniffing out prostate cancer: a new clinical opportunity.

Taverna G, Tidu L, Grizzi F.

Cent European J Urol. 2015;68(3):308-10. doi: 10.5173/ceju.2015.593. Epub 2015 Oct 15. Review. No abstract available.

8.

Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer.

Taverna G, Grizzi F, Colombo P, Seveso M, Giusti G, Proietti S, Fiorini G, Lughezzani G, Casale P, Buffi N, Lazzari M, Guazzoni G.

Korean J Urol. 2015 Jun;56(6):435-42. doi: 10.4111/kju.2015.56.6.435. Epub 2015 Jun 2.

9.

Editorial: Prostate Cancer: What We Know and What We Would Like to Know.

Taverna G, Cote RJ, Grizzi F.

Front Oncol. 2015 May 22;5:114. doi: 10.3389/fonc.2015.00114. eCollection 2015. No abstract available.

10.

Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.

Taverna G, Seveso M, Giusti G, Hurle R, Graziotti P, Stifter S, Chiriva-Internati M, Grizzi F.

Curr Gerontol Geriatr Res. 2014;2014:478126. doi: 10.1155/2014/478126. Epub 2014 Mar 19. Review.

11.

Mast cells as a potential prognostic marker in prostate cancer.

Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F.

Dis Markers. 2013;35(6):711-20. doi: 10.1155/2013/478303. Epub 2013 Nov 11. Review.

12.

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study.

Alongi F, Cozzi L, Arcangeli S, Iftode C, Comito T, Villa E, Lobefalo F, Navarria P, Reggiori G, Mancosu P, Clerici E, Fogliata A, Tomatis S, Taverna G, Graziotti P, Scorsetti M.

Radiat Oncol. 2013 Jul 8;8:171. doi: 10.1186/1748-717X-8-171.

13.

Impact of Real-Time Elastography versus Systematic Prostate Biopsy Method on Cancer Detection Rate in Men with a Serum Prostate-Specific Antigen between 2.5 and 10‚ÄČng/mL.

Taverna G, Magnoni P, Giusti G, Seveso M, Benetti A, Hurle R, Colombo P, Minuti F, Grizzi F, Graziotti P.

ISRN Oncol. 2013;2013:584672. doi: 10.1155/2013/584672. Epub 2013 Jan 16.

14.

Is angiogenesis a hallmark of prostate cancer?

Taverna G, Grizzi F, Colombo P, Graziotti P.

Front Oncol. 2013 Feb 6;3:15. doi: 10.3389/fonc.2013.00015. eCollection 2013. No abstract available.

15.

Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10‚ÄČng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?

Taverna G, Benecchi L, Grizzi F, Seveso M, Giusti G, Piccinelli A, Benetti A, Colombo P, Minuti F, Graziotti P.

J Oncol. 2012;2012:645146. doi: 10.1155/2012/645146. Epub 2012 Jul 12.

16.

Prostatic stromal tumor with fatal outcome in a young man: histopathological and immunohistochemical case presentation.

Colombo P, Ceresoli GL, Boiocchi L, Taverna G, Grizzi F, Bertuzzi A, Santoro A, Roncalli M.

Rare Tumors. 2010 Dec 31;2(4):e57. doi: 10.4081/rt.2010.e57.

17.

Bladder metastases of appendiceal mucinous adenocarcinoma: a case presentation.

Taverna G, Corinti M, Colombo P, Grizzi F, Severo M, Piccinelli A, Giusti G, Benetti A, Zucali PA, Graziotti P.

BMC Cancer. 2010 Feb 23;10:62. doi: 10.1186/1471-2407-10-62.

Supplemental Content

Loading ...
Support Center